GLP-1 Receptor Agonists May Lower Mortality in IMIDs and T2D
GLP-1 RAs were associated with a decreased risk for all-cause mortality and MACE in patients with immune-mediated inflammatory diseases and type 2 diabetes.
Medscape Medical News
source https://www.medscape.com/viewarticle/glp-1-receptor-agonists-may-lower-mortality-immune-mediated-2024a1000fd1?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/glp-1-receptor-agonists-may-lower-mortality-immune-mediated-2024a1000fd1?src=rss
Comments
Post a Comment